Is IGXT or XYLD a better dividend investment in 2026?

IGXT currently yields 1176.47% with a 5% 5-year dividend growth rate. XYLD yields 11.20% with 0.5% growth. The better choice depends on your goal: IGXT offers higher current income.

What is the dividend yield difference between IGXT and XYLD?

IGXT has a forward dividend yield of 1176.47% ($2.00/share annually). XYLD yields 11.20% ($4.30/share annually). The yield gap is 1165.27 percentage points.

Home › Compare › IGXT vs XYLD

IGXT vs XYLD: Dividend Comparison 2026

IGXT yields 1176.47% · XYLD yields 11.20%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IGXT wins by $78814195.18M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IGXT

● Live price

1176.47%

Share price

$0.17

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$78814195.20M

Annual income

$67,523,701,253,088.38

Full IGXT calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

11.20%

Share price

$38.36

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$3,351.03

Full XYLD calculator →

Portfolio growth — IGXT vs XYLD

📍 IGXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IGXT	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IGXT + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IGXT pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IGXT

Annual income on $10K today (after 15% tax)

$100,000.00/yr

After 10yr DRIP, annual income (after tax)

$57,395,146,065,125.13/yr

XYLD

Annual income on $10K today (after 15% tax)

$952.37/yr

After 10yr DRIP, annual income (after tax)

$2,848.38/yr

At 15% tax rate, IGXT beats the other by $57,395,146,062,276.75/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IGXT + XYLD for your $10,000?

IGXT: 50%XYLD: 50%

100% XYLD50/50100% IGXT

Portfolio after 10yr

$39407097.61M

Annual income

$33,761,850,628,219.70/yr

Blended yield

85.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on IGXT right now

IGXT

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-23.8

Piotroski

4/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IGXT buys

XYLD buys

No recent congressional trades found for IGXT or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIGXTXYLD

Forward yield	1176.47% ✓	11.20%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$78814195.20M ✓	$25.9K
Annual income after 10y	$67,523,701,253,088.38 ✓	$3,351.03
Total dividends collected	$77969765.27M ✓	$20.2K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: IGXT vs XYLD ($10,000, DRIP)

Year	IGXT Portfolio	IGXT Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$128,347	$117,647.06	$10,840	$1,120.44	+$117.5K → IGXT
2	$1,548,514	$1,411,182.61	$11,786	$1,249.59	+$1.54M → IGXT
3	$17,569,052	$15,912,142.01	$12,854	$1,397.78	+$17.56M → IGXT
4	$187,523,354	$168,724,468.35	$14,063	$1,568.33	+$187.51M → IGXT
5	$1,883,716,681	$1,683,066,692.55	$15,434	$1,765.19	+$1883.70M → IGXT
6	$17,816,329,317	$15,800,752,468.33	$16,995	$1,993.14	+$17816.31M → IGXT
7	$158,731,384,105	$139,667,911,735.60	$18,777	$2,257.95	+$158731.37M → IGXT
8	$1,332,782,916,056	$1,162,940,335,063.89	$20,818	$2,566.58	+$1332782.90M → IGXT
9	$10,551,863,503,163	$9,125,785,782,982.70	$23,163	$2,927.50	+$10551863.48M → IGXT
10	$78,814,195,201,473	$67,523,701,253,088.38	$25,865	$3,351.03	+$78814195.18M → IGXT

IGXT vs XYLD: Complete Analysis 2026

IGXT — Stock

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Full IGXT Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this IGXT vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IGXT vs SCHD IGXT vs JEPI IGXT vs O IGXT vs KO IGXT vs MAIN IGXT vs QYLD IGXT vs JEPQ IGXT vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.